Search by Drug Name or NDC

    NDC 68382-0354-06 bupropion 300 mg/1 Details

    bupropion 300 mg/1

    bupropion is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 68382-0354
    Product ID 68382-354_59f7c443-2368-4c0b-8f54-ee0e234b79d9
    Associated GPIs 58300040107530
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name bupropion
    Proprietary Name Suffix n/a
    Non-Proprietary Name bupropion
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201567
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0354-06 (68382035406)

    NDC Package Code 68382-354-06
    Billing NDC 68382035406
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-06)
    Marketing Start Date 2014-02-15
    NDC Exclude Flag N
    Pricing Information N/A